These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34565234)

  • 61. Effect of protease inhibitor-based highly active antiretroviral therapy on survival in HIV-associated advanced Kaposi's sarcoma patients treated with chemotherapy.
    Leitch H; Trudeau M; Routy JP
    HIV Clin Trials; 2003; 4(2):107-14. PubMed ID: 12671778
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Kaposi's sarcoma in HIV infected women in Germany: more evidence for sexual transmission. A report of 10 cases and review of the literature.
    Albrecht H; Helm EB; Plettenberg A; Emminger C; Heise W; Schwartländer B; Stellbrink HJ
    Genitourin Med; 1994 Dec; 70(6):394-8. PubMed ID: 7705856
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Regression of Kaposi's sarcoma during therapy with HIV-1 protease inhibitors: a prospective pilot study.
    Krischer J; Rutschmann O; Hirschel B; Vollenweider-Roten S; Saurat JH; Pechère M
    J Am Acad Dermatol; 1998 Apr; 38(4):594-8. PubMed ID: 9555800
    [TBL] [Abstract][Full Text] [Related]  

  • 64. HIV-associated anaemia before and after initiation of antiretroviral therapy at Art Centre of Minilik II Hospital, Addis Ababa, Ethiopia.
    Adane A; Desta K; Bezabih A; Gashaye A; Kassa D
    Ethiop Med J; 2012 Jan; 50(1):13-21. PubMed ID: 22519158
    [TBL] [Abstract][Full Text] [Related]  

  • 65. HIV - associated and non - HIV associated types of Kaposi's sarcoma in an African population in Tanzania. Status of immune suppression and HHV-8 seroprevalence.
    Wamburu G; Masenga EJ; Moshi EZ; Schmid-Grendelmeier P; Kempf W; Orfanos CE
    Eur J Dermatol; 2006; 16(6):677-82. PubMed ID: 17229611
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Dermatologic manifestations among human immunodeficiency virus patients in Morocco and association with immune status.
    Titou H; Ebongo C; Hjira N
    Int J Dermatol; 2018 Feb; 57(2):156-161. PubMed ID: 29243825
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Changes in AIDS-defining illnesses in a London Clinic, 1987-1998.
    Mocroft A; Sabin CA; Youle M; Madge S; Tyrer M; Devereux H; Deayton J; Dykhoff A; Lipman MC; Phillips AN; Johnson MA
    J Acquir Immune Defic Syndr; 1999 Aug; 21(5):401-7. PubMed ID: 10458621
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin.
    Martín-Carbonero L; Palacios R; Valencia E; Saballs P; Sirera G; Santos I; Baldobí F; Alegre M; Goyenechea A; Pedreira J; González del Castillo J; Martínez-Lacasa J; Ocampo A; Alsina M; Santos J; Podzamczer D; González-Lahoz J;
    Clin Infect Dis; 2008 Aug; 47(3):410-7. PubMed ID: 18582203
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Dermoscopic Features of Giant Molluscum Contagiosum in a Patient with Acquired Immunodeficiency Syndrome.
    Sławińska M; Hlebowicz M; Iżycka-Świeszewska E; Sikorska M; Sokołowska-Wojdyło M; Smiatacz T; Gesing M; Nowicki RJ; Sobjanek M
    Acta Dermatovenerol Croat; 2020 Dec; 28(7):233-235. PubMed ID: 33834996
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical and Laboratory Profile of People Living with HIV/AIDS with Oral Kaposi Sarcoma.
    Alves CGB; Assis MS; Maciel ADS; da Silva JC; Leite-Ribeiro PM; Lins-Kusterer L; Sarmento VA
    AIDS Res Hum Retroviruses; 2021 Nov; 37(11):870-877. PubMed ID: 34538064
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Change in T-lymphocyte count after initiation of highly active antiretroviral therapy in HIV-infected patients with history of Mycobacterium avium complex infection.
    Lazaro E; Coureau G; Guedj J; Blanco P; Pellegrin I; Commenges D; Dabis F; Moreau JF; Pellegrin JL; Thiébaut R;
    Antivir Ther; 2006; 11(3):343-50. PubMed ID: 16759051
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Temporal Trends in the Epidemiology of HIV in Turkey.
    Erdinc FS; Dokuzoguz B; Unal S; Komur S; Inkaya AC; Inan D; Karaoglan I; Deveci A; Celen MK; Kose S; Erben N; Senturk GC; Heper Y; Kutlu SS; Hatipoglu CA; Sumer S; Kandemir B; Sirmatel F; Bayindir Y; Yilmaz E; Ersoy Y; Kazak E; Yildirmak MT; Kayaaslan B; Ozden K; Sener A; Kara A; Gunal O; Birengel S; Akbulut A; Yetkin F; Cuvalci NO; Sargin F; Pullukcu H; Gokengin D; Multicentric Hiv Study Group
    Curr HIV Res; 2020; 18(4):258-266. PubMed ID: 32342820
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Immunological profile of endemic and epidemic Kaposi's sarcoma patients in Dar-es-Salaam, Tanzania.
    Urassa WK; Kaaya EE; Kitinya JN; Lema LL; Amir H; Luande J; Biberfeld G; Mhalu FS; Biberfeld P
    Int J Mol Med; 1998 Jun; 1(6):979-82. PubMed ID: 9852634
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Early upper digestive tract side effects of zidovudine with tenofovir plus emtricitabine in West African adults with high CD4 counts.
    Ouattara E; Danel C; Moh R; Gabillard D; Peytavin G; Konan R; Carrou JL; Bohoussou F; Eholie SP; Anglaret X
    J Int AIDS Soc; 2013 Apr; 16(1):18059. PubMed ID: 23639243
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Predictors of first-line antiretroviral therapy failure among adults and adolescents living with HIV/AIDS in a large prevention and treatment program in Nigeria.
    Ndembi N; Murtala-Ibrahim F; Tola M; Jumare J; Aliyu A; Alabi P; Mensah C; Abimiku A; Quiñones-Mateu ME; Crowell TA; Rhee SY; Shafer RW; Gupta R; Blattner W; Charurat ME; Dakum P
    AIDS Res Ther; 2020 Nov; 17(1):64. PubMed ID: 33143751
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Treatment response and mortality among patients starting antiretroviral therapy with and without Kaposi sarcoma: a cohort study.
    Maskew M; Fox MP; van Cutsem G; Chu K; Macphail P; Boulle A; Egger M; Africa FI
    PLoS One; 2013; 8(6):e64392. PubMed ID: 23755122
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Changing patterns of Kaposi's sarcoma in Danish acquired immunodeficiency syndrome patients with complete follow-up. The Danish Study Group for HIV Infection (DASHI).
    Lundgren JD; Melbye M; Pedersen C; Rosenberg PS; Gerstoft J
    Am J Epidemiol; 1995 Apr; 141(7):652-8. PubMed ID: 7702040
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-Infected patients receiving highly active antiretroviral therapy.
    Wilkinson J; Cope A; Gill J; Bourboulia D; Hayes P; Imami N; Kubo T; Marcelin A; Calvez V; Weiss R; Gazzard B; Boshoff C; Gotch F
    J Virol; 2002 Mar; 76(6):2634-40. PubMed ID: 11861829
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Changes in the prevalence of HIV-associated mucosal disease at a dedicated clinic over 7 years.
    Greenwood I; Zakrzewska JM; Robinson PG
    Oral Dis; 2002 Mar; 8(2):90-4. PubMed ID: 11991309
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Treatment of HIV-1-associated Kaposi's sarcoma with pegylated liposomal doxorubicin and HAART simultaneously induces effective tumor remission and CD4+ T cell recovery.
    Lichterfeld M; Qurishi N; Hoffmann C; Hochdorfer B; Brockmeyer NH; Arasteh K; Mauss S; Rockstroh JK;
    Infection; 2005 Jun; 33(3):140-7. PubMed ID: 15940415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.